The Burden of Tick-Borne Encephalitis in Disability-Adjusted Life Years (DALYs) for Slovenia.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 26672751)

Published in PLoS One on December 16, 2015

Authors

Renata Šmit1,2, Maarten J Postma1,2,3

Author Affiliations

1: Department of Pharmacy, Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), University of Groningen, Groningen, Netherlands.
2: Institute for Science in Healthy Aging & healthcaRE (SHARE), University Medical Center Groningen (UMCG), University of Groningen, Groningen, Netherlands.
3: Department of Epidemiology, UMCG, University of Groningen, Groningen, Netherlands.

Articles citing this

Tick-borne encephalitis: what travellers should know when visiting an endemic country. Hum Vaccin Immunother (2016) 0.75

Articles cited by this

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (1997) 29.18

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40

Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ (1994) 10.96

GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64

Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet (1997) 7.29

Disability-adjusted life years: a critical review. J Health Econ (1997) 4.22

Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes. BMJ (2004) 3.94

Understanding DALYs (disability-adjusted life years). J Health Econ (1997) 3.30

Cost-effectiveness of tick-borne encephalitis vaccination in Slovenian adults. Vaccine (2012) 3.25

DALYs: the age-weights on balance. Bull World Health Organ (1996) 3.24

Tick-borne encephalitis. Lancet (2008) 2.99

Tick-borne encephalitis virus - a review of an emerging zoonosis. J Gen Virol (2009) 2.32

Tick-borne encephalitis. Clin Infect Dis (1999) 2.30

The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients. Brain (1999) 1.80

GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet (2012) 1.77

Can the value choices in DALYs influence global priority-setting? Health Policy (2004) 1.76

Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview. Ticks Tick Borne Dis (2010) 1.73

Epidemiology and ecology of TBE relevant to the production of effective vaccines. Vaccine (2003) 1.59

Tick-borne encephalitis in Europe and beyond--the epidemiological situation as of 2007. Euro Surveill (2008) 1.47

Field effectiveness of vaccination against tick-borne encephalitis. Vaccine (2007) 1.37

Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up. Vaccine (2003) 1.30

To what extent has climate change contributed to the recent epidemiology of tick-borne diseases? Vet Parasitol (2009) 1.23

Vaccines for preventing tick-borne encephalitis. Cochrane Database Syst Rev (2009) 1.22

New methodology for estimating the burden of infectious diseases in Europe. PLoS Med (2012) 1.21

Pediatric tick-borne encephalitis in 371 cases from an endemic region in Slovenia, 1959 to 2000. Pediatr Infect Dis J (2003) 1.20

Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis. Clin Infect Dis (2002) 1.20

The burden of infectious diseases in Europe: a pilot study. Euro Surveill (2007) 1.18

The pathogen- and incidence-based DALY approach: an appropriate [corrected] methodology for estimating the burden of infectious diseases. PLoS One (2013) 1.17

Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BMC Public Health (2014) 1.17

Comparison of the epidemiological and clinical features of tick-borne encephalitis in children and adults. Infection (2000) 1.17

TBE vaccination and the Austrian experience. Vaccine (2003) 1.15

A survey on cases of tick-borne encephalitis in European countries. Euro Surveill (2008) 1.10

Tick-borne encephalitis. Infect Dis Clin North Am (2008) 1.01

Adjusting life for quality or disability: stylistic difference or substantial dispute? Health Econ (2009) 0.93

Time to disable DALYs? On the use of disability-adjusted life-years in health policy. Eur J Health Econ (2003) 0.92

TBE--awareness and protection: the impact of epidemiology, changing lifestyle, and environmental factors. Wien Med Wochenschr (2010) 0.92

Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines. Hum Vaccin Immunother (2013) 0.92

High burden of tick-borne encephalitis in Slovenia--challenge for vaccination policy. Vaccine (2011) 0.91

Tick-borne encephalitis in Slovenia from 2000 to 2004: comparison of the course in adult and elderly patients. Wien Klin Wochenschr (2006) 0.90

Underreporting of viral encephalitis and viral meningitis, Ireland, 2005-2008. Emerg Infect Dis (2013) 0.89

Severe forms of tick-borne encephalitis in children. Wien Klin Wochenschr (1999) 0.89

Tick-borne encephalitis in Europe. Acta Leiden (1992) 0.87

Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG). Hum Vaccin Immunother (2013) 0.87

The Golden Agers and Tick-borne encephalitis. Conference report and position paper of the International Scientific Working Group on Tick-borne encephalitis. Wien Med Wochenschr (2005) 0.86

Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in France. Vaccine (1996) 0.86

Tick-borne encephalitis (TBE) in Germany and clinical course of the disease. Int J Med Microbiol (2002) 0.86

[TBE virus infection: clinical and epidemiological data]. Med Mal Infect (2004) 0.85

The current perspective on tick-borne encephalitis awareness and prevention in six Central and Eastern European countries: report from a meeting of experts convened to discuss TBE in their region. Vaccine (2011) 0.85

New foci of tick-borne encephalitis virus in Europe: consequences for travellers from abroad. Travel Med Infect Dis (2003) 0.85

Cellular inflammatory response to flaviviruses in the central nervous system of a primate host. J Histochem Cytochem (2009) 0.82

Tick-borne encephalitis vaccines: past and present. Expert Rev Vaccines (2005) 0.80

Tick-borne encephalitis: from childhood to golden age does increased mobility mean increased risk? Conference report of the 11th meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE). Vaccine (2009) 0.78

Tick-borne encephalitis in the age of general mobility. Wien Med Wochenschr (2010) 0.78

Estimating vaccination coverage against tick-borne encephalitis: comment on: Košnik IG, Lah AK. A campaign to increase the vaccination rate in a highly endemic tick-borne encephalitis region of Slovenia. Vaccine 2013;31(5):732-4. Vaccine (2013) 0.76

Severe tick-borne encephalitis in Slovenia in the years 2001-2005: time for a mass vaccination campaign? Wien Klin Wochenschr (2006) 0.76